191 related articles for article (PubMed ID: 34033838)
1. Binding interaction of protoberberine alkaloids against acetylcholinesterase (AChE) using molecular dynamics simulations and QM/MM calculations.
Honorio P; Sainimnuan S; Hannongbua S; Saparpakorn P
Chem Biol Interact; 2021 Aug; 344():109523. PubMed ID: 34033838
[TBL] [Abstract][Full Text] [Related]
2. Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction.
Honorio P; Hannongbua S; Saparpakorn P
Chem Biol Interact; 2022 Dec; 368():110227. PubMed ID: 36302488
[TBL] [Abstract][Full Text] [Related]
3. Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.
Junaid M; Islam N; Hossain MK; Ullah MO; Halim MA
PLoS One; 2019; 14(2):e0211935. PubMed ID: 30785927
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholinesterase inhibitors from Stephania venosa tuber.
Ingkaninan K; Phengpa P; Yuenyongsawad S; Khorana N
J Pharm Pharmacol; 2006 May; 58(5):695-700. PubMed ID: 16640839
[TBL] [Abstract][Full Text] [Related]
5. The Cholinesterase Inhibitory Properties of Stephaniae Tetrandrae Radix.
Kong XP; Ren HQ; Liu EYL; Leung KW; Guo SC; Duan R; Dong TTX; Tsim KWK
Molecules; 2020 Dec; 25(24):. PubMed ID: 33327436
[TBL] [Abstract][Full Text] [Related]
6. Identification of Human Acetylcholinesterase Inhibitors from the Constituents of EGb761 by Modeling Docking and Molecular Dynamics Simulations.
Zhang L; Li D; Cao F; Xiao W; Zhao L; Ding G; Wang ZZ
Comb Chem High Throughput Screen; 2018; 21(1):41-49. PubMed ID: 29173156
[TBL] [Abstract][Full Text] [Related]
7. Binding interactions and in silico ADME prediction of isoconessimine derivatives as potent acetylcholinesterase inhibitors.
Tue-Ngeun P; Rakitikul W; Thinkumrob N; Hannongbua S; Meelua W; Jitonnom J
J Mol Graph Model; 2024 Jun; 129():108746. PubMed ID: 38401250
[TBL] [Abstract][Full Text] [Related]
8. Binding Analysis of Some Classical Acetylcholinesterase Inhibitors: Insights for a Rational Design Using Free Energy Perturbation Method Calculations with QM/MM MD Simulations.
Nascimento ÉCM; Oliva M; Świderek K; Martins JBL; Andrés J
J Chem Inf Model; 2017 Apr; 57(4):958-976. PubMed ID: 28406297
[TBL] [Abstract][Full Text] [Related]
9. Oxime-dipeptides as anticholinesterase, reactivator of phosphonylated-serine of AChE catalytic triad: probing the mechanistic insight by MM-GBSA, dynamics simulations and DFT analysis.
Chadha N; Tiwari AK; Kumar V; Lal S; Milton MD; Mishra AK
J Biomol Struct Dyn; 2015; 33(5):978-90. PubMed ID: 24805972
[TBL] [Abstract][Full Text] [Related]
10. Identification of molecular descriptors for design of novel Isoalloxazine derivatives as potential Acetylcholinesterase inhibitors against Alzheimer's disease.
Gurung AB; Aguan K; Mitra S; Bhattacharjee A
J Biomol Struct Dyn; 2017 Jun; 35(8):1729-1742. PubMed ID: 27410776
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations.
Malik R; Choudhary BS; Srivastava S; Mehta P; Sharma M
J Biomol Struct Dyn; 2017 Nov; 35(15):3268-3284. PubMed ID: 27782777
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
13. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.
Ghosh S; Chandar NB; Jana K; Ganguly B
J Comput Aided Mol Des; 2017 Aug; 31(8):729-742. PubMed ID: 28646405
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase inhibition of Alzheimer's disease: identification of potential phytochemicals and designing more effective derivatives to manage disease condition.
Koly HK; Sutradhar K; Rahman MS
J Biomol Struct Dyn; 2023; 41(22):12532-12544. PubMed ID: 36651199
[TBL] [Abstract][Full Text] [Related]
15. The discovery of new acetylcholinesterase inhibitors derived from pharmacophore modeling, virtual screening, docking simulation and bioassays.
Zhang Y; Zhang S; Xu G; Yan H; Pu Y; Zuo Z
Mol Biosyst; 2016 Nov; 12(12):3734-3742. PubMed ID: 27801451
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulation of Axillaridine-A: a potent natural cholinesterase inhibitor.
ul-Haq Z; Hadi H; Moin ST; Choudhary MI
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1101-5. PubMed ID: 19555175
[TBL] [Abstract][Full Text] [Related]
17. N-(4-Hydroxyphenyl)-3,4,5-trimethoxybenzamide derivatives as potential memory enhancers: synthesis, biological evaluation and molecular simulation studies.
Piplani P; Sharma M; Mehta P; Malik R
J Biomol Struct Dyn; 2018 May; 36(7):1867-1877. PubMed ID: 28565938
[TBL] [Abstract][Full Text] [Related]
18. Computational studies of acetylcholinesterase complexed with fullerene derivatives: a new insight for Alzheimer disease treatment.
da Silva Gonçalves A; França TC; Vital de Oliveira O
J Biomol Struct Dyn; 2016 Jun; 34(6):1307-16. PubMed ID: 26219766
[TBL] [Abstract][Full Text] [Related]
19. Anti-Acetylcholinesterase Activities of Mono-Herbal Extracts and Exhibited Synergistic Effects of the Phytoconstituents: A Biochemical and Computational Study.
Balkrishna A; Pokhrel S; Tomer M; Verma S; Kumar A; Nain P; Gupta A; Varshney A
Molecules; 2019 Nov; 24(22):. PubMed ID: 31752124
[TBL] [Abstract][Full Text] [Related]
20. Computational evidence of new putative allosteric sites in the acetylcholinesterase receptor.
Moghadam B; Ashouri M; Roohi H; Karimi-Jafari MH
J Mol Graph Model; 2021 Sep; 107():107981. PubMed ID: 34246109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
